A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
This is a 48-week study to evaluate the safety and efficacy of a new tablet formulation
containing two FDA-approved drugs in HIV-infected patients who have not received prior
therapy. This tablet will be taken with one of two FDA-approved drugs as a once-daily
regimen. Study physicians will evaluate subjects to determine if they have certain medical
conditions, laboratory test values, medication use, or drug allergies that would exclude them
from the study.